Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
-complexity domains encode conformational preferences and give rise to condensates with specific emergent properties (e.g., Martin et al. Science 2020, Bremer et al. Nat Chem 2022, Farag et al. Nat Commun 2023
-
-complexity domains encode conformational preferences and give rise to condensates with specific emergent properties (e.g., Martin et al. Science 2020, Bremer et al. Nat Chem 2022, Farag et al. Nat Commun 2023
-
Post Doctoral Researcher in Human-Centered AI for Software Engineering, Department of Electrical ...
The Section for Software Engineering and Computing Systems, at the Department of Electrical and Computer Engineering (ECE), invites applicants for a two-year postdoctoral position within the area of
-
considered an asset Training and experience in quantitative empirical methods Good command of multivariate and complex statistical methods International publications in peer-reviewed journals and / or book
-
, and schools, our diverse community collaborates closely with industry, government, and academia to address complex issues relevant to Asia and the world. Researchers in our faculties and over 40
-
The Ghezzi Lab at University of Massachusetts Lowell is looking for a full-time, fully benefitted Postdoctoral Research Associate to participate in a NIH-funded research program which aims
-
collaboration with the Complexity Science Hub Vienna (CSH). Duration: 30 months (36 hours/week) Location: Vienna, Austria Start date: 1. October 2025 Salary: 4,439.6 Euro / month (brutto) * 14 months
-
-funded financial support for salary or stipends (e.g., National Research Foundation Mid-Career Researcher Program, Jang Young-Shil Fellow, or similar programs), duplicate funding is not allowed. Applicants
-
for artificial intelligence in life sciences, we benefit from high-throughput computing infrastructure to support advanced data analysis and integration. Profile We are looking for a motivated postdoctoral
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe